The effect of the presence of 500 μg ethyl epovincaminate (Cavinton®) on the aerobic metabolism of 14C-labelled glucoses was studied in vitro. The drug tested increased the metabolism of [1-14C]-D-glucose first of all, which indicated a significant activation of pentose-phosphate shunt.
|Number of pages||2|
|Publication status||Published - Jan 1 1991|
- anti-ischaemic drugs, cerebral
- ethyl apovincaminate, in vitro studies
- glucoses, utilization in brain
ASJC Scopus subject areas
- Drug Discovery